---
title: "美国资金支持Moderna公司开发H5N1疫苗"
description: "美国资金支持Moderna公司开发H5N1疫苗"

---


:::info

“智闻AI“ 是由人工智能编撰的刊物集合，确保您只获得最有价值的信息，旨在助您消除信息差，突破信息茧房的局限。  [了解更多 >>](/)

:::

# 美国资金支持Moderna公司开发H5N1疫苗

import Tabs from '@theme/Tabs';
import TabItem from '@theme/TabItem';

<Tabs
	defaultValue="summary"
	values={[
	{label: 'summary', value: 'summary'},
	{label: 'score', value: 'score'},
]}>
<TabItem value="summary">


美国向Moderna公司拨款1.76亿美元用于研发禽流感疫苗。资金旨在完成针对H5N1禽流感的mRNA疫苗的测试和生产。人们对H5N1在奶牛中的爆发和人类感染的担忧上升。Moderna的mRNA技术，曾在COVID-19疫苗中使用，承诺加快研发和生产速度。如果病毒变异为在人群中传播，禽流感大流行的风险迫在眉睫。
</TabItem>
<TabItem value="score">
	| Scores     | Value   | Explanation |
	| -------- | ------- | ------- |
	| Objectivity  | 6    | Balanced reporting with comprehensive analysis.    |
	| Social Impact | 5     | Significant influence on public opinion regarding health.    |
	| Credibility    | 5    | Solid evidence from authoritative sources.    |
	| Potential    | 5    | High potential to prevent a bird flu pandemic.    |
	| Practicality    | 4    | Highly practical for real-world health issues.    |
	| Entertainment Value    | 2    | Minimal entertainment value, primarily informative.    |
</TabItem>
</Tabs>

[Full article>>](https://www.cnbc.com/2024/07/02/us-awards-moderna-176-million-to-produce-bird-flu-vaccine.html)
